Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 10/20 | 1.00 |
| ▸ | CDK1 | P06493 | 3/20 | 1.00 |
| ▸ | GSK3A | P49840 | 3/20 | 1.00 |
| ▸ | CCNB2 | O95067 | 2/20 | 1.00 |
| ▸ | CCNB1 | P14635 | 2/20 | 1.00 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 1.00 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 1.00 |
| ▸ | CDK2 | P24941 | 1/20 | 1.00 |
| ▸ | LIMK1 | P53667 | 1/20 | 1.00 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 1.00 |
| ▸ | SLK | Q9H2G2 | 1/20 | 1.00 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 1.00 |
| ▸ | CSNK1G1 | Q9HCP0 | 1/20 | 1.00 |
| ▸ | IDH1 | O75874 | 4/20 | 0.42 |
| ▸ | TMPRSS4 | Q9NRS4 | 1/20 | 0.36 |
| ▸ | ROS1 | P08922 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Laduviglusib SCHEMBL29353709 | 1.00 | GSK3B (1.00) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29359162 | 1.00 | GSK3B (1.00) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL151139 | 1.00 | GSK3B (1.00) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL30175104 | 0.99 | GSK3B (0.98) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29468026 | 0.99 | GSK3B (0.98) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL18301565 | 0.99 | GSK3B (0.98) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29361792 | 0.99 | GSK3B (0.98) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL240280 | 0.87 | GSK3B (0.77) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29381114 | 0.87 | GSK3B (0.77) | GSK3BCDK1GSK3ACCNB2CCNB1 | |
| Laduviglusib SCHEMBL29838591 | 0.87 | GSK3B (0.77) | GSK3BCDK1GSK3ACCNB2CCNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8312 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3765486-B1 | REAGENTS AND METHODS WITH WNT AGONISTS AND BIOACTIVE LIPIDS FOR GENERATING AND EXPANDING CARDIOMYOCYTES | UNIV LELAND STANFORD JUNIOR (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122090920-A | Multi-parameter feedback intelligent regulation and control method for inducing dental pulp stem cell differentiation by Chir99021 | — | 2026-05-26 | — | — | CN | claimed |
| CN-122080237-A | Preparation method of ovarian stem cells and application of ovarian stem cells in preparation of ovarian anti-aging drugs | — | 2026-05-26 | — | — | CN | claimed |
| CN-122081224-A | Method for constructing humanized brain organoid model of early-onset Alzheimer disease and application of humanized brain organoid model | — | 2026-05-26 | — | — | CN | claimed |
| CN-113633663-B | Application of EPC derived from induced pluripotent stem cell differentiation in preparation of cerebral apoplexy therapeutic agent | Chengnuo regenerative medical technology (Beijing) Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-121575043-B | Method for inducing pluripotent stem cells to differentiate into ovarian granulosa cells and application thereof | Yunnan Saiyuan Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122070916-A | Application of arteannuin with double functions in promoting liver cell maturation and relieving liver lipid metabolism dysfunction | 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） | 2026-05-22 | — | — | CN | claimed |
| WO-2026106780-A1 | PHYSIOLOGICAL AGING AND REJUVENATION OF VITAL HUMAN ORGAN SYSTEMS IN VITRO | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026103625-A1 | METHOD FOR CONSTRUCTING THYMUS ORGANOID AND USE THEREOF | 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） | 2026-05-21 | — | — | WO | claimed |
| US-20260139229-A1 | MULTILINEAGE CARDIOVASCULAR ORGANOIDS AND METHODS OF GENERATING THE SAME | THE UNIV OF CHICAGO (US) | 2026-05-21 | — | — | US | claimed |
| WO-2022023451-A1 | MASS PRODUCTION OF HUMAN PLURIPOTENT STEM CELL DERIVED CARDIAC STROMAL CELL | GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS, UNIVERSITÄTSMEDIZIN (DE) | 2022-02-03 | — | — | WO | claimed |
| US-20220033780-A1 | METHOD FOR PREPARING INTESTINAL ORGANOID DERIVED FROM PLURIPOTENT STEM CELL | PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY (JP) | 2022-02-03 | — | — | US | claimed |
| EP-3945133-A1 | MASS PRODUCTION OF HUMAN PLURIPOTENT STEM CELL DERIVED CARDIAC STROMAL CELL | Georg-August-Universität Göttingen (DE) | 2022-02-02 | — | — | EP | claimed |
| CN-110373380-B | Liver organoid model and establishing method and application thereof | 中国科学院生态环境研究中心 | 2022-01-28 | — | — | CN | claimed |
| US-20220025336-A1 | METHOD FOR PRODUCING INSULIN-PRODUCING CELLS, AND COMPOSITION | KATAOKA CORPORATION (JP) | 2022-01-27 | — | — | US | claimed |
| US-20220025333-A1 | IN VITRO METHOD OF DIFFERENTIATING A HUMAN PLURIPOTENT STEM CELL POPULATION INTO A CARDIOMYOCYTE CELL POPULATION | NCARDIA B.V. (NL) | 2022-01-27 | — | — | US | claimed |
| US-20220025330-A1 | COMPOSITIONS AND METHODS FOR GENERATING HEMATOPOIETIC STEM CELLS (HSCS) | OSPEDALE SAN RAFFAELE S.R.L. (IT) | 2022-01-27 | — | — | US | claimed |
| EP-3942018-A1 | DIRECT REPROGRAMMING OF CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES USING AN ENDOTHELIAL CELL TRANSDIFFERENTIATION STRATEGY | Baylor College of Medicine (US) | 2022-01-26 | — | — | EP | claimed |
| CN-113957036-A | Culture medium and culture method for endometrioid organs | 创芯国际生物科技(广州)有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-113966393-A | Culture medium, composition and method for expanding latent energy stem cells of mammals | 香港大学 | 2022-01-21 | — | — | CN | claimed |